Medicare’s $2,100 Drug Quietly Reshapes Prescription Costs for Investors
Medicare's out-of-pocket cap for covered prescriptions rises to $2,100 in 2026, ending the donut-hole-era for many pa...
Assess tax efficiency between S&P 500 ETFs and index funds for retirement, focusing on taxes, distributions, and long-term strategy.
28,172 articlesMedicare's out-of-pocket cap for covered prescriptions rises to $2,100 in 2026, ending the donut-hole-era for many pa...
Stratasys is stepping into 2025 with a focused plan to diversify revenue, improve margins, and scale software-led ser...
Investors are watching PLBY closely as plby (plby) 2026 earnings unfold. This article breaks down Q1 results, evaluat...
Memory-chip demand remains tight, and Micron's product mix positions it to benefit from AI adoption in data centers. ...
As mortgage rates shift and originations evolve, loandepot (LDI) 2025 earnings will hinge on rate flow, loan mix, and...
Markets have bounced, but a few names still stand out as compelling buys. Here are three stocks you'll regret not own...
BNB Chain rolls out BNB Agent Studio, a platform to deploy autonomous AI agents that can earn crypto and survive infr...
The NYC Council greenlights a 72-story Brooklyn tower with 1,263 units, a quarter permanently affordable. Constructio...
Ford kicked off the year with strong truck demand and a raised outlook. Now the automaker aims to sustain momentum in...
Michael Burry has added a Micron short, expanding a wager that AI-driven chip stocks may soon pull back. The move com...
Two bold paths in clean energy collide: hydrogen fuel cells from Plug Power and small modular nuclear reactors from O...
Alphabet and Meta delivered divergent Q4 results, underscoring different paths to durable profits. Cloud, AI, and cap...